ropivacaine hydrochloride - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
ROPIBAM 0.2% Ropivacaine hydrochloride 400mg/200mL solution for injection bag AUST R: 186571 Active ingredients: ropivacaine hydrochloride Dosage form: Injection, solution Sponsor: Boucher & Muir Pty Ltd Phone: 1800 627 680	From 11 Nov 2024 to 31 Dec 2025	Shortage status: Current Availability: Unavailable Reason: Commercial Changes / Commercial viability Management action: Alternative generic products are available.
NAROPIN 0.2% ropivacaine hydrochloride 400mg/200mL injection bag AUST R: 52395 Active ingredients: ropivacaine hydrochloride Dosage form: Injection, solution Sponsor: Aspen Pharmacare Australia Pty Ltd Phone: 1300659646	Deletion from market: 06 Feb 2025	Shortage status: Discontinued Availability: Unavailable Reason: Commercial Changes / Commercial viability Management action: Alternative generic products are available.
NAROPIN 0.2% WITH FENTANYL 400 microgram/100mL ropivacaine hydrochloride 2 mg/mL and fentanyl 4 microgram/mL (as citrate) 100ml injection bag AUST R: 72876 Active ingredients: fentanyl citrate ropivacaine hydrochloride Dosage form: Injection, solution Sponsor: Aspen Pharmacare Australia Pty Ltd Phone: 1300659646	Deletion from market: 06 Feb 2025	Shortage status: Discontinued Availability: Unavailable Reason: Commercial Changes / Commercial viability Management action: Alternative bag size and strength available.
NAROPIN 0.2% WITH FENTANYL 800 microgram/200mL ropivacaine hydrochloride 2 mg/mL and fentanyl 4 microgram/mL (as citrate) 200mL injection bag AUST R: 72875 Active ingredients: fentanyl citrate ropivacaine hydrochloride Dosage form: Injection, solution Sponsor: Aspen Pharmacare Australia Pty Ltd Phone: 1300659646	Deletion from market: 06 Feb 2025	Shortage status: Discontinued Availability: Unavailable Reason: Commercial Changes / Commercial viability Management action: Alternative strengths are available.